FDA Releases Report on Transparency to Regulated Industry: Not Much To See Here

The third phase of the Food & Drug Administration’s Transparency Initiative lists 19 ways that the agency plans to improve transparency to the industries it regulates. FDA is also seeking comments on five proposed steps. Unlike earlier phases, there isn’t too much to see here.